Symphogen
Agnete Marie Granau has a diverse work experience in the scientific field. From 2016 to 2017, they worked as a Studentermedhjælper at Statens Serum Institut. Agnete Marie then joined Symphogen in 2017 as a Studentermedhjælper and continued until 2021. At Biotech Research and Inovation Center, they worked as a Videnskabelig assistent at Grønbæk Group from 2021 to 2022. Agnete Marie later joined Herlev Hospital, Gastrologisk Afdeling as a Videnskabelig assistent from 2022 to 2023. Currently, they are working at Symphogen as a Scientist, starting in 2023.
Agnete Marie Granau completed their Bachelor of Science degree in Molecular Biomedicine from the University of Copenhagen in 2016. Agnete Marie then pursued further education and obtained their Master of Science degree in Molecular Biomedicine from the same university in 2021.
This person is not in the org chart
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.